Niacinamide

Within the SIRIAM Platform, Niacinamide serves as one of the principal physiological components of the Integration Core.

Following the Release phase, the Integration Core represents the architectural layer intended to support longer-term physiological adaptation within the neurodermal environment. Unlike ingredients selected primarily for inflammatory modulation, Niacinamide was chosen because of its well-characterised roles in cellular metabolism, epidermal homeostasis and tissue physiology.

Within the SIRIAM architecture, Niacinamide functions as a common Integration Core ingredient rather than a Regional Signature Component. Its role is to provide a scientifically established physiological foundation that complements the botanical components of the Integration Core while remaining independent of regional anatomical differentiation.

Its incorporation reflects the SIRIAM philosophy of integrating evidence-supported physiological molecules with carefully selected botanicals into a standardized neurodermal formulation platform.

Niacinamide (nicotinamide) is the biologically active amide form of Vitamin B3 and serves as an essential precursor for the synthesis of the pyridine nucleotides:

Nicotinamide adenine dinucleotide (NAD⁺)

Nicotinamide adenine dinucleotide phosphate (NADP⁺)

These coenzymes are fundamental to cellular energy metabolism, mitochondrial function, DNA repair and numerous enzymatic reactions involved in maintaining tissue homeostasis.

Experimental studies have demonstrated that Niacinamide participates in multiple biological pathways, including:

maintenance of cellular NAD⁺ pools;

modulation of oxidative stress;

regulation of inflammatory signalling;

support of epidermal barrier function;

stimulation of ceramide synthesis;

enhancement of keratinocyte differentiation;

support of DNA repair mechanisms following ultraviolet exposure.

Among all topical vitamins, Niacinamide possesses one of the strongest evidence bases in dermatological science.

Human clinical studies have demonstrated benefits in several dermatological applications, including:

improvement of epidermal barrier integrity;

reduction of transepidermal water loss (TEWL);

enhancement of skin hydration;

reduction of erythema;

improvement of skin texture;

reduction of hyperpigmentation;

improvement of photoaged skin;

support of epidermal repair.

Topical concentrations between 2% and 5% are the most extensively investigated, although higher concentrations have also been evaluated in selected dermatological indications.

Current scientific evidence evaluates Niacinamide primarily as an individual physiological compound within conventional dermatological formulations.

No published studies currently investigate Niacinamide within a region-specific neurodermal formulation architecture comparable to the SIRIAM Platform.

Consequently, its incorporation reflects both its extensive scientific evidence base and the architectural design philosophy of the platform rather than direct evidence for region-specific neurodermal application.

Within the SIRIAM Platform, Niacinamide functions as one of the defining physiological ingredients of the Integration Core.

Its architectural role is to provide a robust evidence-based physiological component that complements the botanical Integration Core while remaining independent of regional anatomical differentiation.

Future pharmaceutical optimisation may refine concentration according to formulation performance while preserving its architectural position within the platform.